General characteristics of the study population, categorised by risk according to Dutch Score, 2011
| Total | Risk <10% | Risk 10–20% | Risk ≥20% | |
|---|---|---|---|---|
| n (%) | 2370 | 1920 (81) | 230 (9.7) | 220 (9.3) |
| Age, years ± SD | 48.0 ± 9.6 | 44.9 ± 7.3 | 58.2 ± 6.7 | 63.8 ± 6.2 |
| Male, % | 47 | 44 | 64 | 62 |
| Current smoker, % | 27.2 | 25.5 | 39.1 | 29.5 |
| Systolic blood pressure, mmHg ± SD | 128.1 ± 18.3 | 124.3 ± 15.8 | 140.7 ± 18.3 | 149.4 ± 17.9 |
| Cholesterol ratio ± SD | 4.4 ± 1.3 | 4.3 ± 1.3 | 4.9 ± 1.3 | 4.8 ± 1.3 |
| Diabetes mellitus, % | 5.1 | 1.2 | 8.7 | 35.0 |
| Rheumatoid arthritis, % | 2.4 | 0.8 | 8.3 | 10.5 |
| BMI, kg/m2 | 26 ± 10.6 | 26 ± 4.2 | 27 ± 4.2 | 27 ± 4.1 |
| Medication use, % | ||||
| Diuretics | 3.3 | 2.3 | 5.7 | 7.3 |
| Beta-blockers | 4.3 | 3.0 | 7.4 | 13.2 |
| Calcium antagonists | 1.2 | 0.6 | 2.6 | 4.5 |
| ACE inhibitors | 4.2 | 2.9 | 5.2 | 14.5 |
| Statins | 1.2 | 2.0 | 10.4 | 11.8 |
| BP lowering | 9.8 | 6.7 | 15.2 | 30.9 |
| Diabetic medication | 1.6 | 0.3 | 2.6 | 11.8 |
| CVD events during follow-up, % | 7.3 | 4.6 | 15.2 | 22.3 |
BMI = body mass index. BP = blood pressure. CVD = cardiovascular disease. SD = standard deviation.